Zenabis Global Inc. (T:ZENA)

Business Focus: N/A

Get the company report for the most recent outlook updated daily

Jun 01, 2021 08:31 am ET

HEXO Corp. and Zenabis Global Inc. Announce Closing of Arrangement

HEXO Corp. ("HEXO") (TSX: HEXO; NYSE: HEXO) and Zenabis Global Inc. ("Zenabis") (TSX: ZENA) are pleased to announce that they have completed the previously announced arrangement (the "Arrangement"), pursuant to which HEXO has acquired all of the...

May 18, 2021 04:50 pm ET

Zenabis Obtains Final Order Approving Plan of Arrangement with HEXO

VANCOUVER, BC, May 18, 2021 /CNW/ - Zenabis Global Inc. ("Zenabis") (TSX: ZENA) today announced that it has obtained a final court order from the Supreme Court of British Columbia approving the previously announced plan of arrangement under the Business Corporations Act (British Columbia), pursuant to which HEXO Corp. ("HEXO") (TSX: HEXO; NYSE-A: HEXO) will acquire all of Zenabis' issued and outstanding common shares ("Zenabis Shares") by way of plan of arrangement (the "Arrangement"). Receipt of the final order follows the special meeting of shareholders of Zenabis held on May 13, 2021 (the

May 14, 2021 10:00 pm ET

Zenabis Announces First Quarter 2021 Financial Results

VANCOUVER, BC, May 14, 2021 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") today announced its financial results for the quarter ended March 31, 2021. All amounts, unless specified otherwise, are expressed in Canadian dollars.

May 14, 2021 07:45 am ET

Zenabis Maltese Joint Venture Partner Zenpharm Receives License for Production & Distribution of Cannabis

VANCOUVER, BC, May 14, 2021 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") announces today that its Maltese joint venture, ZenPharm Limited ("ZenPharm"), has received its Licence for the Production of Cannabis for Medicinal and Research Purposes ("Medicinal Cannabis License") issued by the Malta Medicines Authority, as afforded under Chapter 578 of the laws of Malta.

May 13, 2021 04:04 pm ET

Zenabis Obtains Shareholder Approval for Arrangement With HEXO Corp.

VANCOUVER, BC, May 13, 2021 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") is pleased to announce that, at the special meeting (the "Meeting") of shareholders of the Company ("Company Shareholders") held earlier today, Company Shareholders approved the proposed plan of arrangement under Division 5 of Part 9 of the Business Corporations Act (British Columbia) with HEXO Corp. (TSX:HEXO; NYSE:HEXO) ("HEXO"), which was originally announced on February 16, 2021 (the "Arrangement").

May 07, 2021 07:00 am ET

Leading Independent Proxy Advisors ISS And Glass Lewis Support Arrangement Agreement Between Hexo And Zenabis, Recommend Zenabis Shareholders Vote FOR HEXO Transaction

Leading proxy advisors Institutional Shareholders Services and Glass Lewis recommend Zenabis shareholders vote FOR the Arrangement Resolution and the HEXO Debenture Conversion Resolution at the upcoming Special Meeting of Shareholders Zenabis shareholders are reminded to vote by no later than May 11, 2021 at 10:00 a.m. (Vancouver time) Zenabis shareholders who require assistance with voting can contact Kingsdale Advisors at 1-866-581-0512 (toll-free) VANCOUVER, BC, May 7, 2021 /CNW/ - Zenabis Global Inc. ("Zenabis") (TSX: ZENA) is pleased to announce that the leading independent proxy advi

Apr 07, 2021 05:00 pm ET

Zenabis Announces Receipt of Interim Order for Proposed Arrangement with HEXO Corp.

Also receives Competition Act approval of proposed Arrangement

Mar 31, 2021 10:45 pm ET

Zenabis Announces Full Year and Fourth Quarter 2020 Financial Results

VANCOUVER, BC, March 31, 2021 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") today announced its financial results for the year and quarter ended December 31, 2020. All amounts, unless specified otherwise, are expressed in Canadian dollars.

Mar 24, 2021 07:45 am ET

Zenabis Announces Launch of Re-Up Pre-Roll Multipacks, New Distribution Agreements

VANCOUVER, BC, March 24, 2021 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") announces the launch of pre-roll multipacks as well as new distribution agreements.

Mar 23, 2021 03:45 pm ET

Zenabis Provides Update on Details of Special Meeting of Shareholders for Arrangement with HEXO Corp. and Release and Filing of 2020 Financial Results

VANCOUVER, BC, March 23, 2021 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") announced today that the Company has made the decision to change its special meeting of shareholders to be held for the purpose of submitting the arrangement transaction with HEXO Corp. (the "Arrangement") for shareholder approval (the "Meeting"), which was originally scheduled to be held in person on Thursday, April 15, 2021 in Langley, British Columbia, to a virtual-only meeting to be held on Thursday, May 13, 2021.

Mar 11, 2021 01:00 pm ET

Zenabis Announces Closing of Disposition of Bevo Farms Ltd.

VANCOUVER, BC, March 11, 2021 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") announced today that it has closed the previously announced sale of Bevo Farms Ltd. ("Bevo"), pursuant to the rental rebate, liability contribution and share purchase agreement (the "Agreement") dated December 31, 2020 between Zenabis and Langley Propagation and Floral Company Ltd. ("Langley").

Mar 01, 2021 06:45 am ET

Zenabis Announces Commitment Extension re Revolving Credit Facility

VANCOUVER, BC, March 1, 2021 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") announced today that it has entered into an amending agreement (the "Amending Agreement") in respect of its January 21, 2021 credit agreement (the "Credit Agreement") with a Canadian private debt fund (the "Agent"), as agent on behalf of certain lenders, in respect of a committed revolving credit facility in a principal amount of up to $60 million, subject to satisfaction of the applicable conditions precedent and subject to borrowing base requirements based on eligible receivables, inventory an

Feb 19, 2021 04:03 pm ET

Zenabis Files Court Proceedings Seeking Judicial Interpretation of Debenture

VANCOUVER, BC, Feb. 19, 2021 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") announces that its wholly-owned subsidiary, Zenabis Investments Ltd. ("Zenabis Investments"), has filed a petition with the Supreme Court of British Columbia (the "Court") for a determination of the amount required to repay and terminate its fifth amended and restated debenture (the "Debenture") and to obtain discharges of the Debenture and related security. The Debenture is held by a subsidiary (the "Debenture Lender") of Sundial Growers Inc. ("Sundial"), another licenced cannabis producer and

Feb 16, 2021 11:26 am ET

HEXO Corp. to acquire Zenabis Global Inc.

HEXO Corp. ("HEXO") (TSX: HEXO; NYSE: HEXO) and Zenabis Global Inc. ("Zenabis") (TSX: ZENA) are pleased to announce that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") under which HEXO will acquire, by way...

Feb 16, 2021 10:49 am ET

IIROC Trade Resumption - ZENA

TORONTO, Feb. 16, 2021 /CNW/ - Trading resumes in:

Feb 16, 2021 10:27 am ET

IIROC Trading Halt - ZENA

TORONTO, Feb. 16, 2021 /CNW/ - The following issues have been halted by IIROC:

Feb 09, 2021 10:13 pm ET

Zenabis Announces the Establishment of an At-the-Market Equity Offering Program

Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today announced that it has established an at-the-market equity program (the “ATM Program”) that allows the Company to issue up to C$15,000,000 of common shares in the capital of the...

Feb 01, 2021 06:45 am ET

Zenabis Joint Venture Receives EU GMP Certification

VANCOUVER, BC, Feb. 1, 2021 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") announces today that its Maltese joint venture, ZenPharm Limited ("ZenPharm"), has received European Union Good Manufacturing Practices ("EU GMP") certification issued by the Malta Medicines Authority.

Jan 22, 2021 06:45 am ET

Zenabis Announces $60m Committed Revolving Credit Facility to Refinance Senior Debt held by Sundial Growers

VANCOUVER, BC, Jan. 22, 2021 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to announce that it has entered into a credit agreement (the "Credit Agreement") with a Canadian private debt fund (the "Agent"), as agent on behalf of certain lenders, in respect of a committed revolving credit facility in a principal amount of up to $60 million, subject to borrowing base requirements based on eligible receivables, inventory and real estate (the "Facility").

Jan 06, 2021 06:30 am ET

Zenabis Provides Update on Strategic Alternatives

VANCOUVER, BC, Jan. 6, 2021 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") is providing an update on its review of its strategic alternatives. As previously announced on December 21, 2020, the Company appointed Echelon Capital Markets ("Echelon") as its financial advisor. The Company has been working with Echelon to investigate alternatives to maximize shareholder value.

Jan 04, 2021 06:45 am ET

Zenabis Disposes of Bevo Farms Ltd. and Reduces Debt by $49.5 Million

To receive deferred consideration of $24.7 million

Jan 04, 2021 06:45 am ET

Zenabis Sells $7 Million of Cannabis

Uses proceeds to make $7 million principal repayment due December 31, 2020, to senior lender.

Dec 21, 2020 06:00 am ET

Zenabis Provides Corporate Update

VANCOUVER, BC, Dec. 21, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") today provided a corporate update.

Nov 30, 2020 08:15 am ET

Zenabis Announces Conditional Agreement for the Sale of Zenabis Delta

VANCOUVER, BC, Nov. 30, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") today announced that it has entered into a conditional agreement for the sale of its facility in Delta, British Columbia.

Nov 13, 2020 08:25 am ET

Zenabis Announces Third Quarter 2020 Financial Results

Q3 2020 net revenue from the Cannabis segment increased 61% to $19.0 million from $11.8 million in Q2 2020Q3 2020 kilograms of cannabis sold increased 98% to 7,819 kg from Q2 2020Q3 2020 Adjusted EBITDA of $3.5 million; third consecutive positive quarterQ3 2020 consolidated net revenue of $23.7 million compared to $12.0 million in Q3 2019

Nov 06, 2020 06:30 am ET

Zenabis Announces Initial Shipments of 510-Threaded Vaporizer Line to OCS

VANCOUVER, BC, Nov. 6, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") today announced initial shipments of its Re-Up 510-Threaded Vaporizer cartridge line to the Ontario Cannabis Store ("OCS").

Oct 30, 2020 08:35 pm ET

Zenabis Announces Conversion of Remaining Secured Convertible Notes

VANCOUVER, BC, Oct. 30, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") is pleased to announce that it has entered into an agreement (the "Note Amending Agreement") with the holders (the "Noteholders") of the subordinated secured convertible notes originally issued by Zenabis Investments Ltd. on October 17, 2018, as amended on August 21, 2019, January 31, 2020 and June 1, 2020 other than Agentis Capital (each, a "Note" and collectively, the "Notes"). The Note Amending Agreement provides for the conversion of 100% of the outstanding principal amount and the accrued i

Oct 19, 2020 07:30 am ET

Zenabis Announces Extension of Unsecured Convertible Notes

VANCOUVER, BC, Oct. 19, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") is pleased to announce that it has entered into definitive agreements (the "Note Amending Agreements") with the holders (the "Noteholders") of two of the unsecured convertible notes originally issued by Zenabis Investments Ltd. on October 17, 2018, as amended on January 3, 2019 (each, a "Note" and collectively, the "Notes"). Such Notes have an aggregate principal amount of $6,400,000 with a prior maturity date of October 17, 2020. The key terms of the Note Amending Agreements include:

Sep 23, 2020 10:29 am ET

Zenabis Announces Closing of Public Offering of Units

VANCOUVER, BC, Sept. 23, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") is pleased to announce the closing of the previously announced overnight marketed offering of units of Zenabis ("Units"), including the exercise in part of the over-allotment option (together, the "Offering"). Pursuant to the Offering, the Company sold 89,317,747 Units at a price of $0.085 per Unit for aggregate gross proceeds of $7,592,008.50. Each Unit consisting of a common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant") to purchase a C

Sep 18, 2020 12:30 pm ET

Zenabis Announces Upsize to Previously Announced Public Offering of Units

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Sep 17, 2020 07:45 pm ET

Zenabis Global Inc. Announces Results of Annual General and Special Meeting

VANCOUVER, BC, Sept. 17, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") announces the results of matters voted on at the annual general and special meeting of shareholders of the Company (the "Meeting") held in Langley, British Columbia on September 17, 2020.

Sep 16, 2020 06:11 pm ET

Zenabis Announces Overnight Marketed Public Offering of Units for Proceeds of Approximately 6 Million

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FORDISSEMINATION IN THE UNITED STATES/

Sep 15, 2020 10:33 am ET

REPEAT – AgraFlora’s Subsidiary Farmako Secures Additional Supply of EU-GMP Cannabis via Definitive Supply Agreement with ZenPharm Limited

AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce that its wholly owned subsidiary Farmako GmbH (“Farmako”) has executed the binding supply agreement (the...

Sep 15, 2020 08:00 am ET

AgraFlora’s Subsidiary Farmako Secures Additional Supply of EU-GMP Cannabis via Definitive Supply Agreement with ZenPharm Limited

Sep 15, 2020 07:30 am ET

Zenabis Provides Corporate Update

VANCOUVER, BC, Sept. 15, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") today provided its monthly operational update for August, 2020.

Aug 31, 2020 07:30 am ET

Zenabis Announces First Shipment to Australia

Cannabis Shipment Volume Over First Two Months of Third Quarter ~20% Higher Than Cannabis Shipment Volume Over Entire Second Quarter

Aug 14, 2020 08:05 am ET

Zenabis Announces Second Quarter 2020 Financial Results

Q2 2020 consolidated net revenue of $27.4 million compared to $19.9 million in Q1 2020Q2 2020 Adjusted EBITDA of $3.1 million compared to $2.3 million in Q1 2020Q2 2020 gross margin before fair value on cannabis net revenue of 47.4% compared to 39.7% in Q1 2020

Aug 12, 2020 09:29 am ET

MPX International’s Wholly-Owned Subsidiary, Canveda Inc., Enters Into a Purchase Agreement With Zenabis Ltd. for the Supply of Cannabis

MPX International Corporation (“MPX International”, “MPXI” or the “Corporation”) (CSE:MPXI; OTCQX:MPXOF), a multinational diversified cannabis company, is pleased to announce that its wholly-owned subsidiary, Canveda Inc. (“Canveda”), a licence...

Aug 12, 2020 07:30 am ET

Zenabis Global Inc. Enters Into a Purchase Agreement With MPX International's Wholly-Owned Subsidary, Canveda Inc., for the Supply of Cannabis Flower

TORONTO, Aug. 12, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") has announced entering into a one year supply agreement for high-quality cannabis flower with Canveda Inc. ("Canveda"), a wholly-owned subsidiary of MPX International Corporation ("MPX International", or "MPXI") ), a multinational diversified cannabis company.

Aug 10, 2020 07:30 am ET

Zenabis Provides Corporate Update

VANCOUVER, BC, Aug. 10, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") today provided its monthly operational update for July, 2020.

Aug 05, 2020 10:51 pm ET

Zenabis Global Inc. Adopts Advance Notice Policy

VANCOUVER, BC, Aug. 5, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis") is pleased to announce that Zenabis' board of directors (the "Board") has adopted a new policy that requires advance notice to Zenabis for nominations of directors other than by management, through a requisition for a meeting or by way of a shareholder proposal.

Jul 28, 2020 07:30 am ET

Zenabis Provides Corporate Update

VANCOUVER, BC, July 28, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") today provided a corporate update on its recent activities.

Jul 27, 2020 07:30 am ET

Zenabis Announces Appointment of Permanent Chief Executive Officer Announcement is Result of Successful Executive Search Process Initiated in December of 2019

VANCOUVER, BC, July 27, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") announces the appointment of Shai Altman as President and Chief Executive Officer ("CEO") of the Company, relieving Kevin Coft, Interim CEO, from that position effective 1 September, 2020.

Jul 24, 2020 07:30 am ET

Zenabis Announces Initial Shipments of 510-Threaded Vaporizer Line

VANCOUVER, BC, July 24, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") today announced initial shipments of its Re-Up 510-Threaded Vaporizer line.

Jun 25, 2020 09:31 am ET

Zenabis Announces Closing of Public Offering of Units

VANCOUVER, BC, June 25, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") is pleased to announce the closing of the previously announced overnight marketed offering of units of Zenabis ("Units"), including the exercise in full of the over-allotment option (together, the "Offering"). Pursuant to the Offering, the Company sold 181,290,456 Units at a price of $0.13 per Unit for aggregate gross proceeds of $23,567,760. Each Unit consisting of a common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant") to purchase a Comm

Jun 19, 2020 09:51 am ET

Zenabis Announces Pricing of Public Offering of Units and Upsizing of the Offering to $20,493,704 million

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Jun 18, 2020 04:01 pm ET

Zenabis Announces Public Offering of Units for Proceeds of Approximately $15,000,000 and Extension of Senior Secured Debenture

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Jun 16, 2020 07:30 am ET

Zenabis Provides Corporate Update

VANCOUVER, BC, June 16, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") today provided a corporate update on its recent activities.

Jun 13, 2020 01:45 pm ET

Zenabis Files Amended and Restated Interim Financials and MD&A for Q1 2020

VANCOUVER, BC, June 13, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") announces that following a review by the Company's auditors, the Company has filed amended and restated interim financial statements and management's discussion and analysis for the three months ended March 31, 2020 and 2019.

Jun 05, 2020 07:30 am ET

Zenabis Announces Term Sheet for the Supply of Medical Cannabis to the German Market and Receipt of a License Amendment for Zenabis Stellarton

VANCOUVER, BC, June 5, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") is pleased to announce that it has assigned its binding term sheet with Farmako GmbH ("Farmako") to its subsidiary company ZenPharm for the supply of European Union Good Manufacturing Practices ("EU GMP") certified medicinal cannabis and amended the terms to provide for a minimum volume guarantee. The Company is also pleased to announce the receipt of its sales license amendment for Zenabis Stellarton from Health Canada.

Jun 04, 2020 07:30 am ET

Zenabis Announces Extension and Partial Conversion of Secured Convertible Notes

VANCOUVER, BC, June 4, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") is pleased to announce that it has entered into definitive agreements (the "Note Amending Agreements") with the holders (the "Noteholders") of each of the subordinated secured convertible notes originally issued by Zenabis Investments Ltd. on October 17, 2018, as amended on August 21, 2019 and January 31, 2020 (each, a "Note" and collectively, the "Notes"). The key terms of the Note Amending Agreements include:

May 26, 2020 04:05 pm ET

Zenabis Provides Update on Annual Meeting of Shareholders

VANCOUVER, May 26, 2020 /CNW/ - Zenabis Global Inc. ("Zenabis" or the "Company") announces that, after careful consideration and in accordance with applicable corporate and securities laws and stock exchange rules, it has decided to hold its annual meeting of shareholders at a date in the second half of 2020. The Company is considering an appropriate time and format for its annual meeting of shareholders and will provide further information on its annual meeting of shareholders as soon as it is available.

May 20, 2020 07:30 am ET

Zenabis Obtains EU-GMP Approval to Supply Medical Cannabis to Europe and Amendments to Health Canada License

VANCOUVER, May 20, 2020 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to announce that it has successfully received EU-GMP approval for its Atholville facility and expects to commence commercial export to the European Union in the third quarter of 2020. In addition, the Company is announcing Health Canada approval of additional growing and processing areas at Zenabis Langley.

May 19, 2020 07:30 am ET

Zenabis Announces First Quarter 2020 Financial Results

Q1 2020 Adjusted EBITDA of $2.3 million compares to an EBITDA loss of $10.4 million in the prior quarterQ1 2020 net cannabis revenue increased 18% to $12.6 million from $10.6 million in Q4 2019Q1 2020 gross margin on cannabis net revenue of 40% compared to 32% in Q4 2019Q1 2020 consolidated gross revenue increased 10% to $22.4 million from $20.3 million in Q4 2019

Apr 30, 2020 07:30 am ET

Zenabis Provides Corporate Update

VANCOUVER, April 30, 2020 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today provided a corporate update on its recent activities and the impact of COVID-19 on the market and operations.

Apr 23, 2020 07:30 am ET

Zenabis Announces Amendments to Senior Secured Debenture and Positive Operational Updates

VANCOUVER, April 23, 2020 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to announce that it has signed a definitive agreement (the "Amended and Restated Debenture") with a syndicate of lenders (collectively, the "Senior Lenders") amending and restating its amended and restated secured debenture dated August 21, 2019 (the "Pre-Existing Debenture") representing senior secured debt in the principal amount of $50,000,000 (the "Original Senior Debt") to convert the Pre-Existing Debenture into an amortizing term loan to be repaid by March 31, 2025. The key terms of

Mar 31, 2020 01:11 am ET

Zenabis Announces Fourth Quarter and Year End 2019 Financial Results

2019 gross revenue grew 870% to $72.8 million from $7.5 million in 2018Q4 2019 net cannabis revenue increased 52.4% to $10.8 million from $7.1 million in Q3 20192019 gross margin on cannabis net revenue of 46.9%

Mar 11, 2020 04:30 pm ET

Zenabis Provides Corporate Update

VANCOUVER, March 11, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") today provided a corporate update on its recent activities.

Feb 19, 2020 05:00 am ET

Zenabis Provides Cannabis 2.0 Product and Strategy Update

"Initial indicative demand from our provincial partners is strong. This will make Zenabis one of the first to market." – Kevin Coft, CEO.

Feb 05, 2020 04:30 pm ET

Zenabis Provides Operations Update and Highlights for December 2019

VANCOUVER, Feb. 5, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") is pleased to provide an update on its recent facility construction and licensing activities, sales and marketing highlights and recent cannabis production results.

Jan 16, 2020 04:00 pm ET

Zenabis Provides Operations Update and Highlights for November 2019

VANCOUVER, Jan. 16, 2020 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") is pleased to provide an update on its recent facility construction and licensing activities, sales and marketing highlights and recent cannabis production results.

Jan 16, 2020 05:00 am ET

Zenabis Announces Partial Conversion of Secured Convertible Notes

VANCOUVER, Jan. 16, 2020 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to announce that the holders (the "Noteholders") of the subordinated secured convertible notes of the Company (the "Convertible Notes") have agreed to convert, at a conversion price of $0.155 per common share of the Company (each, a "Common Share"), an aggregate $6,040,176 of the principal amount of the Convertible Notes (the "Immediate Conversion"). An aggregate of 38,968,874 Common Shares will be issued to the Noteholders pursuant to the Immediate Conversion. Following the Immediate Con

Jan 02, 2020 05:30 pm ET

Zenabis Announces Appointment of New Chief Financial Officer

VANCOUVER, Jan. 2, 2020 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced the appointment of Eric Rasmussen as Chief Financial Officer ("CFO"), replacing Mike Smyth, who is retiring.

Dec 16, 2019 05:00 am ET

Zenabis Announces Receipt of License Amendment of Zenabis Langley for an Additional 69% Increase in Total Annual Capacity

VANCOUVER, Dec. 16, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to announce the receipt of the license amendment for Zenabis Langley Part 2A, representing an additional 39,400 kg of licensed annual cultivation capacity.

Dec 11, 2019 05:00 am ET

Zenabis Global Inc. Announces Transition of Chief Executive Officer with Appointment of Kevin Coft

Former CEO Andrew Grieve will continue to contribute as a Zenabis Board member

Dec 09, 2019 08:00 pm ET

Zenabis Announces Details of Completed Over-Subscribed Rights Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Dec 04, 2019 04:00 pm ET

Zenabis Provides Operations Update and Highlights for October 2019

VANCOUVER, Dec. 4, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to provide an update on its recent facility construction and licensing activities and recent cannabis production results.

Nov 28, 2019 05:00 am ET

Zenabis Announces Completion of Over-Subscribed Rights Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

Nov 21, 2019 04:00 pm ET

Zenabis Announces New Appointment to Board of Directors

VANCOUVER, Nov. 21, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced the appointment of Vincent Quan as the newest member of its Board of Directors, effective November 21, 2019.

Nov 14, 2019 06:30 am ET

Zenabis Global Announces Third Quarter 2019 Financial Results

VANCOUVER, Nov. 14, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced its financial results for the third quarter ended September 30, 2019. All amounts, unless specified otherwise, are expressed in Canadian dollars.

Oct 28, 2019 06:00 am ET

Zenabis to Host Investor Conference Call on October 29, 2019 to discuss Rights Offering

VANCOUVER, Oct. 28, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") announces that it will hold an investor conference call in listen-only mode on Tuesday October 29, 2019 at 1:30 p.m. (PDT) to discuss the recently announced offering of rights to holders of Zenabis common shares.

Oct 24, 2019 09:30 am ET

Zenabis Announces Rights Offering to Raise Up To $20.8 Million

Founding Shareholders and Insiders Commit to Strong Participation

Oct 22, 2019 05:00 pm ET

Zenabis Announces Cultivation Agreement with Tantalus Labs

VANCOUVER, Oct. 22, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced that it has entered into an agreement (the "Cultivation Agreement") with Tantalus Labs Ltd. ("Tantalus Labs"), pursuant to which Zenabis will grow and harvest cannabis plants from clones provided by Tantalus Labs.

Oct 21, 2019 06:00 am ET

Zenabis Provides Operations Update for September 2019

VANCOUVER, Oct. 21, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to provide an update on its recent facility construction and licensing activities and recent cannabis production results.

Sep 30, 2019 06:00 am ET

Zenabis Enters into Agreement with PAX Labs to become a PAX Era Brand Partner

Zenabis to be One of Five Licensed Producers to Launch PAX Era Pods in December 2019

Sep 23, 2019 06:00 am ET

Zenabis Announces Receipt of Final License Amendment for Zenabis Atholville

VANCOUVER, Sept. 23, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to announce the licensing of Phase 2C – Part 2 at Zenabis Atholville for an additional 3,000 kg of licensed annual cultivation capacity.

Sep 18, 2019 05:27 pm ET

Zenabis Provides Operations Update for August 2019

VANCOUVER, Sept. 18, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to provide an update on its recent facility construction and licensing activities and its recent cannabis production results.

Sep 10, 2019 06:00 am ET

Zenabis to Supply Recreational Cannabis to Ontario Cannabis Stores

VANCOUVER, Sept. 10, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced that it has entered into a Supply Agreement with the Ontario Cannabis Retail Corporation ("OCS") to supply adult-use recreational cannabis to retailers throughout the province.

Aug 28, 2019 06:00 am ET

Zenabis Provides Operations Update for July 2019

VANCOUVER, Aug. 28, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to provide an update on its recent facility construction and licensing activities and its recent cannabis production results.

Aug 26, 2019 05:12 pm ET

Zenabis Signs Agreement for Entrance into Cannabis-Infused Beverage Market

VANCOUVER, Aug. 26, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced that it has entered into a definitive agreement (the "Agreement") with a Canadian beverage technology company (the "Beverage Partner") that will supply Zenabis with water soluble, odourless, flavourless and colourless cannabis-infused inputs (the "Beverage Inputs"). The Company plans to utilize the technology in the production of cannabis-infused beverages and other cannabis-infused products. With the Beverage Inputs, Zenabis expects to produce cannabis-infused beverages that have ons

Aug 21, 2019 12:54 pm ET

Zenabis Announces $25 Million in Additional Debt Financing and Extension and Partial Conversion of Secured Convertible Notes

VANCOUVER, Aug. 21, 2019 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") is pleased to announce that it has today signed definitive documentation with respect to $25,000,000 (the "New Senior Debt") in new senior secured debt financing (the "Financing") from R.C. Morris Capital Management Ltd. ("RCM"). The Financing has been effected by way of amending and restating the debenture representing senior secured debt in the principal amount of $25,000,000 provided by the existing senior lender (the "Original Senior Debt", and together with the New Senior Debt, the "Senior Debt

Aug 14, 2019 08:00 am ET

Zenabis Global Announces Second Quarter 2019 Financial Results

VANCOUVER, Aug. 14, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced its financial results for the second quarter ended June 30, 2019. All amounts, unless specified otherwise, are expressed in Canadian dollars.

Aug 06, 2019 06:00 am ET

Zenabis Receives Cultivation License for Zenabis Langley, Increasing Total Licensed Annual Cultivation Capacity by More Than 30%

VANCOUVER, Aug. 6, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to announce the receipt of its cultivation license from Health Canada for Zenabis Langley.

Jul 29, 2019 06:00 am ET

Zenabis Announces Increase in Licensed Capacity by More Than 40% and Substantial Completion of Zenabis Atholville

VANCOUVER, July 29, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to announce the licensing of Phase 2C – Part 1 at Zenabis Atholville (an additional 9,800 kg of licensed annual cultivation capacity).

Jul 24, 2019 06:00 am ET

Zenabis Outperforms Design Capacity by 41% in June

VANCOUVER, July 24, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to provide an update on its recent cannabis production figures, facility construction and licensing.

Jul 22, 2019 06:00 am ET

Zenabis Arranges $10 Million Non-Dilutive Financing via Supply Agreement with Starseed Medicinal Inc.

VANCOUVER, July 22, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced that it has entered into an agreement with Starseed Medicinal Inc. ("Starseed") (the "Supply Agreement"), pursuant to which Starseed will advance $10 million to Zenabis (the "Prepaid Amount") in September 2019 in return for Zenabis supplying dried cannabis flower and trim.

Jul 11, 2019 06:00 am ET

Zenabis Closes $30 Million Non-Dilutive Financing via Supply Agreement with Tilray®

VANCOUVER, July 11, 2019 /CNW/ - Zenabis Global Inc.'s (TSX:ZENA) ("Zenabis" or the "Company") wholly-owned subsidiary, Zenabis Ltd., has closed its previously-announced non-dilutive financing via a pre-paid supply agreement with High Park Holdings Ltd. ("High Park") (the "Supply Agreement"), a wholly-owned subsidiary of Tilray, Inc. (NASDAQ:TLRY) ("Tilray").

Jul 09, 2019 06:00 am ET

Zenabis Submits Site Evidence Package to Health Canada for Langley Facility

VANCOUVER, July 9, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced that it has submitted its site evidence package (the "Site Evidence Package") to Health Canada for the first phase of Site A at Zenabis Langley.

Jul 08, 2019 06:00 am ET

Zenabis Announces Closing of Previously Announced Amendment and Extension of $25 Million Credit Facility

VANCOUVER, July 8, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis" or the "Company") (TSX:ZENA) is pleased to announce that it has completed the amendment (the "Amendment") to its $25,000,000 credit facility (the "Facility") initially announced on July 2, 2019. Pursuant to the Amendment, the maturity date of the Facility has been extended from October 17, 2019 to July 5, 2020. The terms of the Facility, including the interest rate and the financial covenants, will otherwise remain substantially the same, except that the prepayment penalty has been substantially reduced.

Jul 02, 2019 09:51 am ET

IIROC Trade Resumption - ZENA

TORONTO, July 2, 2019 /CNW/ - Trading resumes in:

Jul 02, 2019 09:41 am ET

IIROC Trading Halt - ZENA

TORONTO, July 2, 2019 /CNW/ - The following issues have been halted by IIROC:

Jul 02, 2019 09:35 am ET

Zenabis Arranges $30 Million Non-Dilutive Financing via Supply Agreement with Tilray®

VANCOUVER, July 2, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") today announced that its wholly-owned subsidiary, Zenabis Ltd., has entered into an agreement with High Park Holdings Ltd. ("High Park") (the "Supply Agreement"), a wholly-owned subsidiary of Tilray, Inc. (NASDAQ:TLRY) ("Tilray"), pursuant to which High Park will advance CAD $30 million to Zenabis (the "prepaid amount") in return for a supply of dried cannabis from Zenabis.

Jul 02, 2019 09:00 am ET

Zenabis Announces Amendment and Extension of $25 Million Credit Facility

VANCOUVER, July 2, 2019 /CNW/ – Further to its press release of February 8, 2019, Zenabis Global Inc. ("Zenabis" or the "Company") (TSX:ZENA) is pleased to announce that it has signed a Commitment Letter (the "Commitment Letter") with the lender for its $25,000,000 credit facility (the "Facility") to amend and restate the secured debenture governing the terms thereof (the "Amendment").

Jun 26, 2019 06:00 am ET

Zenabis Global Inc. Announces Results of Annual General and Special Meeting

VANCOUVER, June 26, 2019 /CNW/ - Zenabis Global Inc. (TSX: ZENA) ("Zenabis" or the "Company") announces the results of matters voted on at the annual general and special meeting of shareholders of the Company held in Langley, British Columbia on June 25, 2019.

Jun 24, 2019 06:00 am ET

Zenabis Outperforms Design Capacity by 35% in May and Announces 70% Increase in Licensed Annual Cultivation Capacity

VANCOUVER, June 24, 2019 /CNW/ - Zenabis Global Inc. (TSX:ZENA) ("Zenabis" or the "Company") is pleased to provide an update on its recent cannabis production figures; facility construction and licensing; hemp cultivation; and Zen Craft Grow.

Jun 19, 2019 08:30 am ET

Zenabis Chief Growing Officer Outlines Potential in Exclusive Interview--CFN Media

Seattle, Washington--(Newsfile Corp. - June 19, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering an exclusive interview with Leo Benne, Chief Growing Officer of Zenabis Global Inc. (TSX: ZENA).

Jun 05, 2019 11:58 am ET

Zenabis Global Inc. Opens the Market

TORONTO, June 5, 2019 /CNW/ - Andrew Grieve, Chief Executive Officer, Zenabis Global Inc. (ZENA), joined Michael Kousaie, Vice-President, Strategy and Product Innovation, Toronto Stock Exchange and TSX Venture Exchange, to open the market. Zenabis is a Canadian licensed cannabis cultivator of medical and recreational cannabis, and a propagator and cultivator of floral and vegetable products. Zenabis employs staff coast-to-coast, across facilities in Atholville, New Brunswick; Delta, Aldergrove, Pitt Meadows and Langley, British Columbia; and Stellarton, Nova Scotia. Zenabis Global Inc. gradu

Jun 03, 2019 06:00 am ET

Zenabis Announces Receipt of Industrial Hemp Production License and Other Licensing Updates

Hemp to be Cultivated for Cannabidiol ("CBD") Production

May 30, 2019 10:42 pm ET

Zenabis Global Announces First Quarter 2019 Financial Results

Results Reflect Rapid Corporate Development and Significant Revenue Momentum

May 24, 2019 06:00 am ET

Zenabis Announces Graduation to the Toronto Stock Exchange

VANCOUVER, May 24, 2019 /CNW/ - Zenabis Global Inc. (TSXV:ZENA) ("Zenabis" or the "Company") is pleased to announce that it has received final approval for the listing of the Company's common shares ("Common Shares") and outstanding listed common share purchase warrants ("Warrants") on the Toronto Stock Exchange (the "TSX"). The Company's Common Shares and Warrants will begin trading on the TSX effective as of market open on May 27, 2019. The Common Shares will continue to trade under the symbol "ZENA" and the Warrants will continue to trade under the symbol "ZENA.WT". In conjunction with li

May 21, 2019 06:00 am ET

Zenabis Announces New Appointment to Board of Directors

VANCOUVER, May 21, 2019 /CNW/ - Zenabis Global Inc. (TSXV:ZENA) ("Zenabis" or the "Company") today announced the appointment of Natascha Kiernan, an experienced international finance and M&A attorney who has held senior positions at several prominent international law firms, as the newest member of its Board of Directors, effective May 20, 2019.

May 21, 2019 06:00 am ET

Zenabis Provides Operational Update for April 2019

VANCOUVER, May 21, 2019 /CNW/ - Zenabis Global Inc. (TSXV:ZENA) ("Zenabis" or the "Company") is pleased to provide an update on its recent cannabis production figures; anticipated future harvests; facility construction and licensing status; and medical program update.

May 13, 2019 06:00 am ET

Zenabis Announces Increase in Licensed Capacity by More Than 30% and Provides Date for Next Operational Update

VANCOUVER, May 13, 2019 /CNW/ - Zenabis Global Inc. (TSXV:ZENA) ("Zenabis" or the "Company") is pleased to announce the licensing of Phase 2A at its Zenabis Atholville facility (an additional 3,200kg of cannabis cultivation capacity) and disclose the date of its next operational update: May 21, 2019 (for the month of April 2019).

May 08, 2019 09:00 am ET

Zenabis Building a Cannabis Giant Across Canada -- CFN Media

Seattle, Washington--(Newsfile Corp. - May 8, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article covering Zenabis Global Inc. (TSXV: ZENA) and its aggressive cannabis production model. With licensed facilities in British Columbia, New Brunswick, and Nova Scotia, near-term and large-scale expansion plans, and supply agreements in place across the country, Zenabis is aiming to take its place among Canada's very largest licensed producers. It's worth taking a look at this company that has flown under the radar a bit in terms of production capacity and nationwide distribution.

May 02, 2019 08:23 pm ET

Zenabis Announces Grant of Stock Options

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

Apr 29, 2019 08:30 am ET

Zenabis Provides Operational and Corporate Updates and Files Sun Pharm Investments Ltd. Year End Financial Statements on SEDAR

VANCOUVER, April 29, 2019 /CNW/ - Zenabis Global Inc. (TSXV:ZENA) ("Zenabis" or the "Company") is pleased to provide a comprehensive update on its recent cannabis production figures; the results of its current growing approach on harvest yield; facility construction and licensing status; anticipated future harvest; and latest corporate developments, including management changes. In addition, the Company has filed the financial statements and MD&A for Sun Pharm Investments Ltd. ("Sun Pharm", representing Zenabis' cannabis business prior to the amalgamation with Bevo Agro Inc.) for the yea

Apr 29, 2019 06:00 am ET

Zenabis Partners with Farmako to Supply Mass Produced CBD Isolate in Canada and Medical Cannabis to Germany

VANCOUVER, April 29, 2019 /CNW/ - Zenabis Global Inc. (TSXV:ZENA) ("Zenabis" or the "Company") is pleased to announce that it has entered into a binding term sheet for a three-year supply arrangement with leading German pharmaceutical research company Farmako GmbH ("Farmako") for: (1) the supply of biosynthetically produced pure CBD isolate oil (99.9%) from Farmako to Zenabis for sale in Canada; and (2) the supply of European Union Good Manufacturing Practices ("EU GMP") certified cannabis cultivated in Zenabis' indoor facilities in Canada for sale by Farmako to the German medical market.

Apr 23, 2019 06:00 am ET

Zenabis Expands Recreational Cannabis Product Offerings in Key Domestic Markets

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Apr 22, 2019 06:00 am ET

Zenabis Conditionally Approved to Graduate to the Toronto Stock Exchange

VANCOUVER, April 22, 2019 /CNW/ - Zenabis Global Inc. (TSXV:ZENA) ("Zenabis" or the "Company") is pleased to announce that it has received conditional approval to graduate its listing from the TSX Venture Exchange (the "TSXV") to the Toronto Stock Exchange (the "TSX").

Apr 17, 2019 08:52 am ET

Zenabis Closes Previously Announced Public Offering and Exercise of Over-allotment Option

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Apr 11, 2019 04:17 pm ET

IIROC Trading Resumption - ZENA

VANCOUVER, April 11, 2019 /CNW/ - Trading resumes in:

Apr 11, 2019 03:30 pm ET

Zenabis Announces Pricing and Update to Terms of Public Offering

Zenabis Global Inc (TSXV:ZENA) (“Zenabis” or the “Company”) announces that, further to the Company's press release dated April 10, 2019, its fully-marketed, “best efforts” offering (the "Offering") will be of units of the Company (each, a "Unit")...

Apr 11, 2019 10:12 am ET

IIROC Trading Halt - ZENA

VANCOUVER, April 11, 2019 /CNW/ - The following issues have been halted by IIROC:

Apr 11, 2019 09:54 am ET

IIROC Trading Resumption - ZENA

VANCOUVER, April 11, 2019 /CNW/ - Trading resumes in:

Apr 10, 2019 04:20 pm ET

Zenabis Files Preliminary Prospectus Supplement for Offering of Common Shares

Zenabis Global Inc (TSXV:ZENA) (“Zenabis” or the “Company”) announces that it has today filed a preliminary prospectus supplement (the “Supplement”) to its short form base shelf prospectus dated April 9, 2019 (the “Shelf Prospectus”) in connection...

Apr 10, 2019 03:22 pm ET

IIROC Trading Halt - ZENA

VANCOUVER, April 10, 2019 /CNW/ - The following issues have been halted by IIROC:

Apr 10, 2019 06:00 am ET

Zenabis Announces Appointment of New Chief Financial Officer and Files Final Base Short Form Prospectus

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Apr 01, 2019 09:55 pm ET

Zenabis Global Inc. Announces Resignation of Donald Fairholm from Board of Directors

VANCOUVER, April 1, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (TSXV: ZENA) wishes to announce that Donald Fairholm has resigned from its board of directors. Zenabis would like to thank Mr. Fairholm for his contribution to the company. The board of directors has initiated the process of finding a new director to fill the vacancy on the board.

Mar 27, 2019 04:21 pm ET

Zenabis Completes $15 million First Tranche of $75 million Convertible Debenture Financing

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Mar 21, 2019 10:00 am ET

Drink it Up; Cannabis/Hemp Infused Beverage Distribution Agreements In Full Swing

Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot focusing on the latest distribution agreements for cannabis/hemp infused beverages as companies prepare for legal sales. There has been an...

Mar 21, 2019 06:00 am ET

Zenabis Enters European Pharmaceutical Cannabis Market

VANCOUVER, March 21, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (TSXV: ZENA) today announced a significant expansion of its supply opportunity through its entrance into the European pharmaceutical cannabis market. Zenabis has entered into a Letter of Intent ("LOI") towards a definitive supply arrangement with Farmako GmbH ("Farmako"), a research-based pharmaceutical company headquartered in Frankfurt, Germany.

Mar 19, 2019 06:00 am ET

Zenabis Launches Zen Craft Grow: Program to Connect Micro-Cultivators to National Consumers

VANCOUVER, March 19, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (TSXV: ZENA) has signed its first exclusive, definitive supply agreement under its Zen Craft Grow program. This first Zen Craft Grow agreement is an exclusive supply agreement between Zenabis, as a standard processor, and a micro-cultivator in the final stages of receiving its license that will bring unique genetics and small-batch, artisanally grown cannabis to discerning adult-use consumers across Canada.

Mar 18, 2019 06:28 pm ET

Zenabis Provides Operational Update

Also provides update on Convertible Debenture financing and announces filing of Preliminary Base Shelf Prospectus

Mar 18, 2019 04:14 pm ET

Horizons ETFs Rebalances the Horizons Marijuana Life Sciences Index ETF

Quarterly rebalance includes a leading U.S.-based CBD producer

Mar 18, 2019 06:00 am ET

Zenabis Now Licensed to Sell Cannabis Oil

Key approval paves the way for new product and market opportunities

Mar 14, 2019 03:04 pm ET

Zenabis Confirms Fire at Langley Warehouse; No Injuries or Impact on Cannabis Production or Construction Timelines

VANCOUVER, March 14, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (TSXV: ZENA) today confirmed a minor fire incident on March 14, 2019 at its Bevo Agro facility in Langley, British Columbia. This incident will not affect its cannabis production or cannabis supply commitments.

Mar 04, 2019 07:30 am ET

Zenabis Announces $75 million Convertible Debenture Financing

Zenabis Global Inc (TSXV:ZENA) (“Zenabis” or the “Company”) is pleased to announce that it has entered into a letter of engagement with Eight Capital (the “Eight Capital Engagement”) under which Eight Capital has agreed to purchase 15,000 unsecured...

Mar 04, 2019 05:00 am ET

Zenabis Receives License in Nova Scotia for Third Cannabis Facility

Adds 255,000 square feet of indoor licensed cannabis facility

Feb 26, 2019 05:00 am ET

Quebec Becomes Ninth Canadian Jurisdiction for Zenabis Products

VANCOUVER, Feb. 26, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (TSXV: ZENA) today secured a meaningful new market opportunity by reaching a letter of intent with the Société québécoise du cannabis (SQDC). Quebec is a significant cannabis market and is in close proximity to Zenabis' licensed 380,000 sq. ft. growing facility in New Brunswick, and its upcoming 255,000 sq. ft. facility in Nova Scotia.

Feb 20, 2019 05:00 am ET

Zenabis to Supply Premium Recreational Cannabis to Alberta

Becomes eighth province/territory for Zenabis products

Feb 08, 2019 04:12 pm ET

Zenabis Provides Update on Previous Financing

VANCOUVER, Feb. 8, 2019 /CNW/ – Zenabis Global Inc. ("Zenabis") (TSXV: ZENA) is pleased to provide an update on a previously-announced Secured Convertible Debenture financing. Zenabis issued a secured convertible debenture in October 2017, on which it drew $4,150,000 on October 17, 2018. In connection with completion of its RTO, Zenabis was not permitted to draw the remaining $20,850,000.

Feb 06, 2019 02:50 pm ET

Zenabis Provides Update on Plan of Arrangement, Engages Investment Marketing Firm

VANCOUVER, Feb. 6, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (TSXV: ZENA) today provided an update on the expected tax impact of the Plan of Arrangement completed on January 8, 2019, and announced that it has engaged an investment marketing firm to help increase Zenabis' profile with the investment community.

Feb 04, 2019 05:00 am ET

Zenabis Enters into Supply Agreement with Shoppers Drug Mart

VANCOUVER, Feb. 4, 2019 /CNW/ - Zenabis Global Inc. ("Zenabis") (TSXV: ZENA) is pleased to announce that it has entered into a supply agreement with Shoppers Drug Mart ("Shoppers").

Jan 29, 2019 06:49 pm ET

Corrected: Zenabis Acquires 51% Stake in A Canadian Kombucha Maker

Zenabis has completed the acquisition of 51% of Hillsboro Corp Inc., a Canadian cultured tea beverage company known for its True Buch Kombucha, adding a new product line

Jan 28, 2019 09:34 am ET

Zenabis Global Inc. Opens the Market

TORONTO, Jan. 28, 2019 /CNW/ - Mark Catroppa and Rick Brar, Co-Founders, alongside Andrew Grieve, CEO, Zenabis Global Inc. (ZENA), joined Brady Fletcher, Managing Director, TSX Venture Exchange, to open the market. Zenabis is a licensed producer of medical and recreational cannabis, and employs staff coast-to-coast, across facilities in Atholville, New Brunswick; Delta and Langley, British Columbia; and Stellarton, Nova Scotia. Zenabis Global Inc. commenced trading on TSX Venture Exchange on January 10, 2019.

Jan 28, 2019 05:00 am ET

Zenabis Acquires 51% Stake in a Canadian Kombucha Maker

Zenabis has completed the acquisition of 51% of Hillsboro Corp Inc., a Canadian cultured tea beverage company known for its True Buch Kombucha, adding a new product line

Jan 23, 2019 11:54 am ET

Zenabis Completes Strategic Acquisition of Topgro and Refinances Existing Debt

Zenabis – through its subsidiary Bevo – has completed the acquisition of Topgro, with 10.4 acres of greenhouse on 50 acres of land

Jan 21, 2019 07:05 am ET

Zenabis Enters Into Credit Agreement with a Major Canadian Chartered Bank for $51,000,000 Credit Facility

Zenabis has entered into a $51,000,000 credit agreement for credit facilities, provided by a major Canadian chartered bank for the purposes of repayment of existing Bevo Farms Ltd. debt, the intended acquisition of Topgro and conversion of the Langley Facility for cannabis production

Jan 21, 2019 07:00 am ET

Ad blocking detected

Zenabis Global Inc. (T:ZENA)

Business Focus: N/A